-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Century Therapeutics, Lowers Price Target to $2

Benzinga·04/03/2025 10:59:41
Listen to the news
HC Wainwright & Co. analyst Mitchell Kapoor maintains Century Therapeutics (NASDAQ:IPSC) with a Buy and lowers the price target from $5 to $2.